tuberculosis (TB)

See the following -

Global Health Observatory – The One-Stop Shop For Health Data

Staff Writer | World Health Organization | December 1, 2012

A researcher wanting to find out which countries have the highest rates of tuberculosis can find it hard to pin down the latest information or decipher it from hundreds of columns of numbers often presented in a format that can overwhelm even the most passionate data analyst. Read More »

GSK Expands Open-Source Research Project In TB

Staff Writer | PMLIVE | October 11, 2012

GlaxoSmithKline (GSK) has screened its entire pharmaceutical compound library of more two million compounds and identified about 200 hits with potential against tuberculosis (TB), which it will make available to external research teams as part of its drive towards an 'open innovation' approach to R&D. Read More »

Harnessing New Technologies To Tackle An Old Disease

Dr. Yanis Ben Amor and Sarah Snidal | Huffington Post | March 23, 2013

Though more than 3,500 people worldwide died of tuberculosis (TB) today, you won't see it reported in headlines of any major American newspaper. Neither will you see that March 24 is World TB Day simply because for many Americans it is a disease that doesn't hit home, but this could quickly change. Read More »

How Superbugs Threaten Your Food And Life

Sanchita Sharma | Hindustan Times | May 10, 2014

...This worrying problem causing as much global concern as terrorism is antibiotic resistance. Antibiotics, the wonder drugs that made surgery safe and stopped disease outbreaks by preventing and curing all infections four decades ago, can no longer do so...

Read More »

India's Open Source Drug Discovery Program Faces Lack Of Funding

Marcus Johnson | Bioresearch Online | April 7, 2014

India's Open Source Drug Discovery Program, or OSDD, ran out of funding last week, as the ministry of science and technology did not clear the cabinet note to extend the project's funding on time. OSDD was created in 2008 in an effort to develop new drugs to treat neglected diseases, including Tuberculosis, Malaria, and Leishmaniasis.

Read More »

Japanese Drugmakers Open 'Libraries' In $100 Million Health Project

Ben Hirschler | Reuters | May 30, 2013

Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientists hunting new treatments for malaria, tuberculosis and other diseases affecting the world's poor. Read More »

Let's Pay For Open Source With A Closed-Source Software Levy

Glyn Moody | ComputerWorld UK | October 22, 2014

This column has often explored ways in which some of the key ideas underlying free software and open source are being applied in other fields. But that equivalence can flow in both directions: developments in fields outside the digital world may well have useful lessons for computing...

Read More »

Major Patent Pool Opens Up Research On Neglected Disease

Yojana Sharma | SciDev.Net | October 31, 2011

Research on drug development for neglected tropical diseases (NTDs), tuberculosis and malaria will receive a boost from a major initiative launched by the World Intellectual Property Organization (WIPO) last week (26 October). Read More »

Medicines Shouldn't Be A Luxury - Médecins Sans Frontières

Staff Writer | MSF Access | January 28, 2015

What if the medicines that could save your life cost a hundred times what you earn in a year?  Many people in developing countries can’t get hold of the treatment they need to stay alive and healthy...

Read More »

Open Data Key To Tackling Neglected Tropical Diseases

Open data access could promote collaborations among researchers in Africa and help in the fight against malaria, tuberculosis (TB) and neglected tropical diseases such as sleeping sickness, also called African trypanosomiasis. At a time when demand for open data in health and drug discovery is dominating the digital space, some researchers say the model could work for Africa and alleviate the sufferings of many from these diseases. Following the call on 23 April this year from the WHO for the disclosure of all results from clinical trials of new medicines, there is a push towards greater transparency.

Read More »

Open Source Effort Develops Affordable Drugs

Press Release | Stevens Institute of Technology | March 14, 2013

In order to accelerate the development of new drugs to combat and cure major infectious diseases, Professor A.K. Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative. Read More »

OSDD Starts Youtube Competition For TB

Staff Writer | BioSpectrum | November 2, 2012

India's Open Source Drug Discovery initiative and Vigyan Prasar have called for videos based on the theme, 'The need for TB drugs'. Participants need to be at least 18 years of age and can either upload the video on Youtube or send the video as an email attachment to the authorities, before Nov 26 Read More »

Startup Emocha's App To Help Baltimore Patients Manage Tuberculosis

Sarah Gantz | Baltimore Business Journal | October 27, 2014

Baltimore health IT startup Emocha Mobile Health Inc. is partnering with Baltimore City to test out its medication adherence application with tuberculosis patients...

Read More »

Stevens Professor Joins Open Source Effort To Develop Low-Cost Drugs

Press Release | Stevens Institute of Technology | March 16, 2013

Professor A.K. Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative... Read More »

TB Drug Project Gets a Lease of Life

Jacob Koshy | The Hindu | December 20, 2016

There is also interest from BRICS countries to commit funds for research, says ICMR chief Read More »